Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl-Heinz Klempnauer

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Oncotarget|March 13, 2023
C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cellsKarl-Heinz Klempnauer
International Journal of Molecular Sciences|March 28, 2024
Transcription Factor MYB as Therapeutic Target: Current DevelopmentsKarl-Heinz Klempnauer
Experimental Hematology|January 15, 2022
C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional moduleKarl-Heinz Klempnauer
Oncogene|May 29, 2003
Transactivation mediated by B-Myb is dependent on TAF(II)250Thorsten Bartusel, Karl-Heinz Klempnauer
Biochimica Et Biophysica Acta|April 16, 2016
A conserved patch of hydrophobic amino acids modulates Myb activity by mediating protein-protein interactionsSandeep Dukare, Karl-Heinz Klempnauer
Oncogene|June 26, 2002
Targeted disruption of c-myb in the chicken pre B-cell line DT40Hartmut Appl, Karl-Heinz Klempnauer
Oncogene|July 4, 2002
Identification and characterization of the Myb-inducible promoter of the chicken adenosine receptor 2B geneDana Kattmann, Karl-Heinz Klempnauer
The Journal of Biological Chemistry|August 20, 2009
Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein betaNils Wethkamp, Karl-Heinz Klempnauer
FEBS Letters|March 31, 2021
The CDC37-HSP90 chaperone complex co-translationally degrades the nascent kinase-dead mutant of HIPK2Jan Paul Müller, Karl-Heinz Klempnauer
Molecules (Basel, Switzerland)|April 12, 2022
Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription ModuleThomas J Schmidt, Karl-Heinz Klempnauer
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Oncotarget|March 13, 2023
C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cellsKarl-Heinz Klempnauer
International Journal of Molecular Sciences|March 28, 2024
Transcription Factor MYB as Therapeutic Target: Current DevelopmentsKarl-Heinz Klempnauer
Experimental Hematology|January 15, 2022
C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional moduleKarl-Heinz Klempnauer
Oncogene|May 29, 2003
Transactivation mediated by B-Myb is dependent on TAF(II)250Thorsten Bartusel, Karl-Heinz Klempnauer
Biochimica Et Biophysica Acta|April 16, 2016
A conserved patch of hydrophobic amino acids modulates Myb activity by mediating protein-protein interactionsSandeep Dukare, Karl-Heinz Klempnauer
Oncogene|June 26, 2002
Targeted disruption of c-myb in the chicken pre B-cell line DT40Hartmut Appl, Karl-Heinz Klempnauer
Oncogene|July 4, 2002
Identification and characterization of the Myb-inducible promoter of the chicken adenosine receptor 2B geneDana Kattmann, Karl-Heinz Klempnauer
The Journal of Biological Chemistry|August 20, 2009
Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein betaNils Wethkamp, Karl-Heinz Klempnauer
FEBS Letters|March 31, 2021
The CDC37-HSP90 chaperone complex co-translationally degrades the nascent kinase-dead mutant of HIPK2Jan Paul Müller, Karl-Heinz Klempnauer
Molecules (Basel, Switzerland)|April 12, 2022
Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription ModuleThomas J Schmidt, Karl-Heinz Klempnauer
Pageof 6